Autopsy report · NCT01656395
A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012)
Cause of deathNo reason given
Life of this trial
- Registered 2 months before it started.
- Ran for about 1 year 11 months before it stopped.
- 576 participants enrolled.
- Results were posted on the registry 4 years 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Merck Sharp & Dohme LLC
- Sponsor type
- Industry
- Conditions
- Asthma
- Interventions
- MK-1029; Montelukast 10 mg; Placebo
- Participants
- 576
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.